Peter A Riedell (Peter Riedell)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 28

Top Topics

Acute Lymphoblastic Leukemia

Disease Activity

Epstein Barr Virus

Top Venues

Targeted oncology

Blood cancer journal

This page only lists publications with an associated author ORCID identifier.

Publications

Peter A Riedell
BsAbs before CD19 CAR-T: full speed ahead! Blood 144 (3) (2024)
Peter A Riedell
BsAbs before CD19 CAR-T: full speed ahead! Blood 144 (3) (2024)
Martin Dreyling, Nathan Hale Fowler, Michael J Dickinson, Joaquin Martinez Lopez, Arne Kolstad, Jason P Butler, Monalisa Ghosh, Leslie L Popplewell, Julio C Chavez, Emmanuel Bachy, Koji Kato, Hideo Harigae, Marie José Kersten, Charalambos Andreadis, Peter A Riedell, P Joy Ho, José Antonio Pérez-Simón, Andy I Chen, Loretta J Nastoupil, Bastian von Tresckow, Andrés José Maria Ferreri, Takanori Teshima, Piers E M Patten, Joseph P McGuirk, Andreas L Petzer, Fritz Offner, Andreas Viardot, Pier Luigi Luigi Zinzani, Ram Malladi, Ines Paule, Aiesha Zia, Rakesh Awasthi, Xia Han, Davide Germano, Darragh O'Donovan, Roberto Ramos, Harald J Maier, Aisha Masood, Catherine Thieblemont, Stephen J Schuster
Durable response after tisagenlecleucel in adults with relapsed/refractory follicular lymphoma: ELARA trial update. Blood 143 (17) (2024)
Mazyar Shadman, Kwang W Ahn, Manmeet Kaur, Lazaros Lekakis, Amer Beitinjaneh, Madiha Iqbal, Nausheen Ahmed, Brian Hill, Nasheed M Hossain, Peter A Riedell, Ajay K Gopal, Natalie Sophia Grover, Matthew Frigault, Jonathan Brammer, Nilanjan Ghosh, Reid W Merryman, Aleksander Lazaryan, Ron Ram, Mark Hertzberg, Bipin P Savani, Farrukh Awan, Farhad Khimani, Sairah A Ahmed, Vaishalee P Kenkre, Matthew L Ulrickson, Nirav N Shah, Mohamed A Kharfan-Dabaja, Alex Herrera, Craig Sauter, Mehdi Hamadani
Autologous transplant vs. CAR-T therapy in patients with DLBCL treated while in complete remission. Blood cancer journal 14 (1) (2024)
Nathan Hale Fowler, Julio C Chavez, Peter A Riedell
Moving T-Cell Therapies into the Standard of Care for Patients with Relapsed or Refractory Follicular Lymphoma: A Review. Targeted oncology 19 (4) (2024)
Martin Dreyling, Nathan Hale Fowler, Michael J Dickinson, Joaquin Martinez Lopez, Arne Kolstad, Jason P Butler, Monalisa Ghosh, Leslie L Popplewell, Julio C Chavez, Emmanuel Bachy, Koji Kato, Hideo Harigae, Marie José Kersten, Charalambos Andreadis, Peter A Riedell, P Joy Ho, José Antonio Pérez-Simón, Andy I Chen, Loretta J Nastoupil, Bastian von Tresckow, Andrés José Maria Ferreri, Takanori Teshima, Piers E M Patten, Joseph P McGuirk, Andreas L Petzer, Fritz Offner, Andreas Viardot, Pier Luigi Luigi Zinzani, Ram Malladi, Ines Paule, Aiesha Zia, Rakesh Awasthi, Xia Han, Davide Germano, Darragh O'Donovan, Roberto Ramos, Harald J Maier, Aisha Masood, Catherine Thieblemont, Stephen J Schuster
Durable response after tisagenlecleucel in adults with relapsed/refractory follicular lymphoma: ELARA trial update. Blood 143 (17) (2024)
Mazyar Shadman, Kwang W Ahn, Manmeet Kaur, Lazaros Lekakis, Amer Beitinjaneh, Madiha Iqbal, Nausheen Ahmed, Brian Hill, Nasheed M Hossain, Peter A Riedell, Ajay K Gopal, Natalie Sophia Grover, Matthew Frigault, Jonathan Brammer, Nilanjan Ghosh, Reid W Merryman, Aleksander Lazaryan, Ron Ram, Mark Hertzberg, Bipin P Savani, Farrukh Awan, Farhad Khimani, Sairah A Ahmed, Vaishalee P Kenkre, Matthew L Ulrickson, Nirav N Shah, Mohamed A Kharfan-Dabaja, Alex Herrera, Craig Sauter, Mehdi Hamadani
Autologous transplant vs. CAR-T therapy in patients with DLBCL treated while in complete remission. Blood cancer journal 14 (1) (2024)
Nausheen Ahmed, William Wesson, Forat Lutfi, David L Porter, Veronika Bachanova, Loretta J Nastoupil, Miguel-Ángel Perales, Richard T Maziarz, Jamie Brower, Gunjan L Shah, Andy I Chen, Olalekan O Oluwole, Stephen J Schuster, Michael R Bishop, Joseph P McGuirk, Peter A Riedell
Optimizing the Post-CAR T Monitoring Period for Axicabtagene Ciloleucel, Tisagenlecleucel, and Lisocabtagene Maraleucel. Blood advances (2024)
Nathan Hale Fowler, Julio C Chavez, Peter A Riedell
Moving T-Cell Therapies into the Standard of Care for Patients with Relapsed or Refractory Follicular Lymphoma: A Review. Targeted oncology 19 (4) (2024)
Nathan Hale Fowler, Julio C Chavez, Peter A Riedell
Correction to: Moving T‑Cell Therapies into the Standard of Care for Patients with Relapsed or Refractory Follicular Lymphoma: A Review. Targeted oncology (2024)
Mazyar Shadman, Kwang W Ahn, Manmeet Kaur, Lazaros Lekakis, Amer Beitinjaneh, Madiha Iqbal, Nausheen Ahmed, Brian Hill, Nasheed M Hossain, Peter A Riedell, Ajay K Gopal, Natalie Sophia Grover, Matthew Frigault, Jonathan Brammer, Nilanjan Ghosh, Reid W Merryman, Aleksander Lazaryan, Ron Ram, Mark Hertzberg, Bipin P Savani, Farrukh Awan, Farhad Khimani, Sairah A Ahmed, Vaishalee P Kenkre, Matthew L Ulrickson, Nirav N Shah, Mohamed A Kharfan-Dabaja, Alex Herrera, Craig Sauter, Mehdi Hamadani
Autologous transplant vs. CAR-T therapy in patients with DLBCL treated while in complete remission. Blood cancer journal 14 (1) (2024)
Nathan Hale Fowler, Julio C Chavez, Peter A Riedell
Moving T-Cell Therapies into the Standard of Care for Patients with Relapsed or Refractory Follicular Lymphoma: A Review. Targeted oncology 19 (4) (2024)
Nathan Hale Fowler, Julio C Chavez, Peter A Riedell
Moving T-Cell Therapies into the Standard of Care for Patients with Relapsed or Refractory Follicular Lymphoma: A Review. Targeted oncology 19 (4) (2024)
Nathan Hale Fowler, Julio C Chavez, Peter A Riedell
Moving T-Cell Therapies into the Standard of Care for Patients with Relapsed or Refractory Follicular Lymphoma: A Review. Targeted oncology (2024)
Martin Dreyling, Nathan Hale Fowler, Michael J Dickinson, Joaquin Martinez Lopez, Arne Kolstad, Jason P Butler, Monalisa Ghosh, Leslie L Popplewell, Julio C Chavez, Emmanuel Bachy, Koji Kato, Hideo Harigae, Marie José Kersten, Charalambos Andreadis, Peter A Riedell, P Joy Ho, José Antonio Pérez-Simón, Andy I Chen, Loretta J Nastoupil, Bastian von Tresckow, Andrés José Maria Ferreri, Takanori Teshima, Piers E M Patten, Joseph P McGuirk, Andreas L Petzer, Fritz Offner, Andreas Viardot, Pier Luigi Luigi Zinzani, Ram Malladi, Ines Paule, Aiesha Zia, Rakesh Awasthi, Xia Han, Davide Germano, Darragh O'Donovan, Roberto Ramos, Harald J Maier, Aisha Masood, Catherine Thieblemont, Stephen J Schuster
Durable response after tisagenlecleucel in adults with relapsed/refractory follicular lymphoma: ELARA trial update. Blood 143 (17) (2024)
Ajay Major, Jovian Yu, Navika Shukla, Yan Che, Theodore G Karrison, Rachel Treitman, Manali Kamdar, Bradley M Haverkos, James Godfrey, Melissa A Babcook, Timothy J Voorhees, Sophie Gabrielle Carlson, Daria Gaut, Caspian Oliai, Jason T Romancik, Allison M Winter, Brian T Hill, Radhika Bansal, Jose C Villasboas Bisneto, Imran A Nizamuddin, Reem Karmali, Lindsey A Fitzgerald, Deborah M Stephens, Priyanka A Pophali, Asaad Trabolsi, Jonathan H Schatz, Marie Hu, Veronika Bachanova, Michael Joseph Slade, Nathan Singh, Nausheen Ahmed, Joseph P McGuirk, Michael R Bishop, Peter A Riedell, Justin Kline
Efficacy of checkpoint inhibition after CAR-T failure in aggressive B-cell lymphomas: Outcomes from 15 U.S. institutions. Blood advances (2023)
Michael Scordo, Jessica R Flynn, Mithat Gönen, Sean M Devlin, Allison Parascondola, Ana Alarcon Tomas, Roni Shouval, Jamie Brower, David L Porter, Stephen J Schuster, Veronika Bachanova, Joseph Maakaron, Richard T Maziarz, Andy I Chen, Loretta J Nastoupil, Joseph P McGuirk, Olalekan O Oluwole, Andrew Ip, Lori A Leslie, Michael R Bishop, Peter A Riedell, Miguel-Ángel Perales
Identifying an Optimal Fludarabine Exposure for Improved Outcomes after CD19 CAR T cell therapy for Aggressive B-NHL. Blood advances (2023)
Yazeed Sawalha, Subir Goyal, Jeffrey M Switchenko, Jason T Romancik, Manali Kamdar, Irl Brian Greenwell, Brian T Hess, Krista M Isaac, Craig A Portell, Alex V Mejia Garcia, Scott R Goldsmith, Natalie S Grover, Peter A Riedell, Reem Karmali, Madelyn Burkart, Michael J Buege, Othman S Akhtar, Pallawi Torka, Anita Kumar, Brian T Hill, Brad S Kahl, Jonathon B Cohen
A Multicenter Analysis of the Outcomes with Venetoclax in Patients with Relapsed Mantle Cell Lymphoma. Blood advances (2023)
Kitsada Wudhikarn, Ana Alarcon Tomas, Jessica R Flynn, Sean M Devlin, Jamie Brower, Veronika Bachanova, Loretta J Nastoupil, Joseph P McGuirk, Richard T Maziarz, Olalekan O Oluwole, Stephen J Schuster, David L Porter, Michael R Bishop, Peter A Riedell, Miguel-Ángel Perales
Low toxicity and excellent outcomes in patients with DLBCL without residual lymphoma at the time of CD19 CAR T-cell therapy. Blood advances (2022)
Ulrich Jäger, Nina Worel, Joseph P McGuirk, Peter A Riedell, Isabelle Fleury, Yan Du, Xia Han, David Pearson, Santiago Redondo, Edmund K Waller
Safety and efficacy of tisagenlecleucel plus pembrolizumab in patients with r/r DLBCL: results from the phase Ib PORTIA study. Blood advances (2022)
James Godfrey, Hongtao Liu, Jovian Yu, Michael Tallarico, Emily Curran, Andrew S Artz, Peter A Riedell, Wendy Stock, Theodore Karrison, Carrie Fitzpatrick, Girish Venkataraman, Alan Cooper, Sonali M Smith, Michael R Bishop, Justin Kline
Pembrolizumab for the treatment of disease relapse following allogeneic hematopoietic stem cell transplantation. Blood advances (2022)
Shakthi T Bhaskar, Vivek G Patel, David L Porter, Stephen J Schuster, Loretta J Nastoupil, Miguel-Ángel Perales, Ana Alarcon Tomas, Michael R Bishop, Joseph P McGuirk, Richard T Maziarz, Andy Chen, Veronika Bachanova, Joseph Maakaron, Peter A Riedell, Olalekan O Oluwole
Chimeric antigen receptor T-cell therapy yields similar outcomes in patients with and without cytokine release syndrome. Blood advances (2022)
Misha C Tran, Yasmin Hasan, Amy Y Wang, Kamil M Yenice, Julien Partouche, Wendy Stock, Richard A Larson, Satyajit Kosuri, James L LaBelle, Justin Kline, Peter A Riedell, Andrew S Artz, Ralph R Weichselbaum, Michael R Bishop, Bulent Aydogan, Hongtao Liu
A phase 1 trial utilizing TMI with fludarabine-melphalan in patients with hematologic malignancies undergoing second allo-SCT. Blood advances (2022)
Peter A Riedell, Meng Wu, Jennifer M Collins, Jacklyn M Gideon, Andrzej J Jakubowiak, Justin P Kline, Satyajit Kosuri, Hongtao Liu, Sonali M Smith, Michael R Bishop
Bloodless chimeric antigen receptor (CAR) T-cell therapy in Jehovah's Witnesses. Leukemia & lymphoma 62 (6) (2021)
Peter A Riedell, Mehdi Hamadani, Kwang W Ahn, Carlos Litovich, Claudio G Brunstein, Amanda F Cashen, Jonathon B Cohen, Narendranath Epperla, Brian T Hill, Annie Im, David J Inwards, John Lister, John M McCarty, Sai Ravi Kiran Pingali, Mazyar Shadman, Paul Shaughnessy, Melhem Solh, Patrick J Stiff, Julie M Vose, Mohamed A Kharfan-Dabaja, Alex F Herrera, Craig S Sauter, Sonali M Smith
Effect of time to relapse on overall survival in patients with mantle cell lymphoma following autologous haematopoietic cell transplantation. British journal of haematology 195 (5) (2021)
Tanya Siddiqi, Jacob D Soumerai, Kathleen A Dorritie, Deborah M Stephens, Peter A Riedell, Jon E Arnason, Thomas J Kipps, Heidi H Gillenwater, Lucy Gong, Lin Yang, Ken Ogasawara, Jerill Thorpe, William George Wierda
Phase 1 TRANSCEND CLL 004 study of lisocabtagene maraleucel in patients with relapsed/refractory CLL or SLL. Blood (2021)
Jonathan A Trujillo, James K Godfrey, Yifei Hu, Jun Huang, Sonali M Smith, Matthew J Frigault, Zachariah DeFilipp, Daniel Appelbaum, Yonglin Pu, Nicholas Feinberg, Thomas Althaus, Michael R Bishop, Peter A Riedell, Justin Kline
Primary resistance to CD19-directed chimeric antigen receptor T-cell therapy in T-cell/histiocyte-rich large B-cell lymphoma. Blood 137 (24) (2021)
Peter A Riedell, Michael R Bishop
Safety and efficacy of axicabtagene ciloleucel in refractory large B-cell lymphomas. Therapeutic advances in hematology 11 (2020)